212 related articles for article (PubMed ID: 19016026)
21. Extended-field radiation therapy with whole pelvis radiotherapy and cisplatin chemosensitization in the treatment of IB2-IIIB cervical carcinoma: a retrospective review.
Ring KL; Young JL; Dunlap NE; Andersen WA; Schneider BF
Am J Obstet Gynecol; 2009 Jul; 201(1):109.e1-6. PubMed ID: 19398095
[TBL] [Abstract][Full Text] [Related]
22. Influence of dose point and inverse optimization on interstitial cervical and oropharyngeal carcinoma brachytherapy.
Ahmad F; Aletti P; Charra-Brunaud C; Van der Laarse R; Lapeyre M; Hoffstetter S; Peiffert D; Nöel A
Radiother Oncol; 2004 Dec; 73(3):331-7. PubMed ID: 15588879
[TBL] [Abstract][Full Text] [Related]
23. PET-guided IMRT for cervical carcinoma with positive para-aortic lymph nodes-a dose-escalation treatment planning study.
Mutic S; Malyapa RS; Grigsby PW; Dehdashti F; Miller TR; Zoberi I; Bosch WR; Esthappan J; Low DA
Int J Radiat Oncol Biol Phys; 2003 Jan; 55(1):28-35. PubMed ID: 12504033
[TBL] [Abstract][Full Text] [Related]
24. Position shifts and volume changes of pelvic and para-aortic nodes during IMRT for patients with cervical cancer.
Schippers MG; Bol GH; de Leeuw AA; van der Heide UA; Raaymakers BW; Verkooijen HM; Jürgenliemk-Schulz IM
Radiother Oncol; 2014 Jun; 111(3):442-5. PubMed ID: 25034933
[TBL] [Abstract][Full Text] [Related]
25. [What technique for what tumor? Ethical and methodological issues: cervical cancer].
Barillot I
Cancer Radiother; 2014 Oct; 18(5-6):360-4. PubMed ID: 25179248
[TBL] [Abstract][Full Text] [Related]
26. Three-dimensional treatment planning for postoperative radiotherapy in patients with node-positive cervical cancer. Comparison between a conventional and a conformal technique.
Olofsen-van Acht MJ; Quint S; Seven M; van Santvoort JP; van den Berg HA; Logmans A; Levendag PC
Strahlenther Onkol; 1999 Sep; 175(9):462-9. PubMed ID: 10518981
[TBL] [Abstract][Full Text] [Related]
27. [Surgical lymph-node evaluation in cervical cancer].
Mathevet P
Cancer Radiother; 2009 Oct; 13(6-7):499-502. PubMed ID: 19660975
[TBL] [Abstract][Full Text] [Related]
28. Radiation-related predictors of hematologic toxicity after concurrent chemoradiation for cervical cancer and implications for bone marrow-sparing pelvic IMRT.
Albuquerque K; Giangreco D; Morrison C; Siddiqui M; Sinacore J; Potkul R; Roeske J
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1043-7. PubMed ID: 20471182
[TBL] [Abstract][Full Text] [Related]
29. An interlaced IMRT technique for elongated tumor volumes.
Meyer J; Richter A; Pfreundner L; Guckenberger M; Krieger T; Schwab F; Flentje M
Med Dosim; 2009; 34(2):170-8. PubMed ID: 19410147
[TBL] [Abstract][Full Text] [Related]
30. Clinical evaluation of dynamic arc conformal radiotherapy for paraaortic lymph node metastasis.
Aoki T; Nagata Y; Mizowaki T; Kokubo M; Negoro Y; Takayama K; Mitsumori M; Sasai K; Hiraoka M
Radiother Oncol; 2003 Apr; 67(1):113-8. PubMed ID: 12758247
[TBL] [Abstract][Full Text] [Related]
31. High dose three-dimensional conformal boost (3DCB) using an orthogonal diagnostic X-ray set-up for patients with gynecological malignancy: a new application of real-time tumor-tracking system.
Yamamoto R; Yonesaka A; Nishioka S; Watari H; Hashimoto T; Uchida D; Taguchi H; Nishioka T; Miyasaka K; Sakuragi N; Shirato H
Radiother Oncol; 2004 Nov; 73(2):219-22. PubMed ID: 15542169
[TBL] [Abstract][Full Text] [Related]
32. Calculation and prediction of the effect of respiratory motion on whole breast radiation therapy dose distributions.
Cao J; Roeske JC; Chmura SJ; Salama JK; Shoushtari AN; Boyer AL; Martel MK
Med Dosim; 2009; 34(2):126-32. PubMed ID: 19410141
[TBL] [Abstract][Full Text] [Related]
33. Adaptive management of cervical cancer radiotherapy.
Tanderup K; Georg D; Pötter R; Kirisits C; Grau C; Lindegaard JC
Semin Radiat Oncol; 2010 Apr; 20(2):121-9. PubMed ID: 20219550
[TBL] [Abstract][Full Text] [Related]
34. Hypofractionated intensity-modulated arc therapy for lymph node metastasized prostate cancer.
Fonteyne V; De Gersem W; De Neve W; Jacobs F; Lumen N; Vandecasteele K; Villeirs G; De Meerleer G
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1013-20. PubMed ID: 19386427
[TBL] [Abstract][Full Text] [Related]
35. Lymphatic drainage and CTV in breast cancer.
Nardone L; Terribile D; Belli P; Aristei C
Rays; 2003; 28(3):303-9. PubMed ID: 15018318
[TBL] [Abstract][Full Text] [Related]
36. Critical organ preservation in reirradiation brachytherapy by injectable spacer.
Kishi K; Sonomura T; Shirai S; Sato M; Tanaka K
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):587-94. PubMed ID: 19735885
[TBL] [Abstract][Full Text] [Related]
37. Molecular PET/CT imaging-guided radiation therapy treatment planning.
Zaidi H; Vees H; Wissmeyer M
Acad Radiol; 2009 Sep; 16(9):1108-33. PubMed ID: 19427800
[TBL] [Abstract][Full Text] [Related]
38. Irradiating the groin nodes without breaking a leg: a comparison of techniques for groin node irradiation.
Gilroy JS; Amdur RJ; Louis DA; Li JG; Mendenhall WM
Med Dosim; 2004; 29(4):258-64. PubMed ID: 15528067
[TBL] [Abstract][Full Text] [Related]
39. [Radiotherapy for anal canal cancers].
Peiffert D; Créhange G; Vendrely V; Baumann AS; Faivre JC; Huger S
Cancer Radiother; 2016 Sep; 20 Suppl():S183-8. PubMed ID: 27523411
[TBL] [Abstract][Full Text] [Related]
40. [Stereotactic body radiotherapy (SBRT)].
Nagata Y; Takayama K; Matsuo Y; Norihisa Y; Mizowaki T; Sakamoto M; Yano S; Narita Y; Yamamoto T; Hiraoka M
Gan To Kagaku Ryoho; 2006 Apr; 33(4):455-61. PubMed ID: 16612153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
